TSK Laboratory

SURECUT was unique and offered physicians and the pathologists working with them a new tool in diagnosing Cancer and other diseases. SURECUT became a market leading biopsy needle and over time was copied by many companies. The advantages of that product have also improved diagnosis, and thereby allowing the appropriate treatment, which again, has saved millions of lives around the world. After TSK Laboratory Europe was established in 2010, TSK began producing needle products for the Aesthetics market. In the years that we have been producing these products, TSK Laboratory has improved the lives of hundreds of millions of people around the world. Over the past two decades, TSK Laboratory went through several manufacturer plant expansion plans. We currently have three different production sites in Japan, global offices in Japan, Canada, The Netherlands, China and soon to be expected in the USA and Australia. At our facilities, we dedicate ourselves to apply the highest quality standards, from product development to production, in order to ensure the safety of every patient that is being treated with our products.